X4 Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
XFOR X4 Pharmaceuticals Inc
$SPMDCCBSA S&P 400 - Cable & Satellite(Sub Ind)
BAC Bank of America Corp
SLRC Solar Capital Ltd
ORTX Orchard Therapeutics PLC
TOO-E Teekay Offshore Partners LP
TBT ProShares UltraShort 20+ Year Treasury
ASDTX AllianzGI Short Duration High Income Fund
ETR Entergy Corp
ET Energy Transfer LP
Go

Company profile

X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.

Closing Price
$22.98
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
30,975
0
  • Prev Close
    22.98
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    31.0K
  • Last (time)
    3:59p ET 03/21/19
  • Last (size)
    68
  • 52-Wk Range
    6.90 - 161.61
    LowHigh
  • (03/21/18 - 11/14/18)
    233.04%
  • 224.9%
  • Market Cap
    336.5M
  • Shares Outstanding
    14.6M
  • -18.04
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 427.89
  • (% of float 02/28/19)
    8.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.